{"id":"W2229483068","doi":"10.1016/s0140-6736(15)01120-4","title":"Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":850,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Royal Victoria Hospital; University of British Columbia; Hôpital Maisonneuve-Rosemont; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Refractory (planetary science); Internal medicine; Clinical endpoint; Clinical trial; Phases of clinical research; Surrogate endpoint; Proteasome inhibitor; Surgery; Gastroenterology; Oncology; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002049053,0.002079323,0.003683257,0.0003659059,0.000456232,0.001314022,0.000807407,0.002124461,0.005780953],"category_scores_gemma":[0.001794409,0.000788444,0.002807385,0.0004036874,0.001179964,0.001261408,0.0005704027,0.00329354,0.001177887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007546128,"about_ca_system_score_gemma":0.0009010539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008435485,"about_ca_topic_score_gemma":0.001953314,"domain_scores_codex":[0.9992487,0.0004180716,0.00004314239,0.0001317009,0.00004996331,0.0001084831],"domain_scores_gemma":[0.9991735,0.0002927266,0.0001884774,0.00006521137,0.00004871871,0.0002314529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9858664,0.001653404,0.0004400277,0.0007581651,0.001388685,0.00004505857,0.00005410737,0.0002104054,0.001434633,0.00009946887,0.0007803895,0.00726927],"study_design_scores_gemma":[0.9790869,0.0187613,0.0008627688,0.00002890765,0.0004673479,0.00003013397,0.00001653429,0.0001269038,0.00009517266,0.00009077638,0.0004239842,0.000009359315],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791569,0.0113297,0.0006371333,0.001519142,0.001119459,0.002251835,0.001409409,0.0001340638,0.002442351],"genre_scores_gemma":[0.9787726,0.006965518,0.002054409,0.002457047,0.0008904976,0.002756733,0.001872904,0.0000354752,0.004194884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005780953,"threshold_uncertainty_score":0.01933926,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07518314198563648,"score_gpt":0.3707187301208377,"score_spread":0.2955355881352012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}